Genix Pharmaceuticals Corporation (GENPF)
OTCMKTS
· Delayed Price · Currency is USD
0.0400
+0.0140 (53.85%)
At close: Jun 17, 2024
Genix Pharmaceuticals Revenue
Genix Pharmaceuticals had revenue of 3.98K CAD in the twelve months ending January 31, 2025, down -63.27% year-over-year. In the fiscal year ending October 31, 2024, Genix Pharmaceuticals had annual revenue of 4.05K, down -67.19%.
Revenue (ttm)
3.98K CAD
Revenue Growth
-63.27%
P/S Ratio
465.22
Revenue / Employee
1.00 CAD
Employees
4,000
Market Cap
1.28M USD
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Glass House Brands | 200.90M |
Northwest Biotherapeutics | 1.38M |
Elite Pharmaceuticals | 70.00M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Silence Therapeutics | 43.26M |
Genix Pharmaceuticals News
- 1 year ago - Genix Announces TSX-V Approval of Warrant Amendments - Newsfile Corp
- 1 year ago - Genix Announces Warrant Repricing and Seeks Extension - Newsfile Corp
- 2 years ago - Genix Announces AGM Results - Newsfile Corp
- 2 years ago - Genix Receives Approval to Extend Warrants from the TSX Venture Exchange - Newsfile Corp
- 3 years ago - Genix Proposes to Extend Warrants - Newsfile Corp